ASTRAZENECA SAYS FARXIGA REDUCED DEATH FROM ANY CAUSE BY 31% IN PATIENTS WITH CHRONIC KIDNEY DISEASE (CKD) IN DAPA-CKD TRIAL
Stock Market News in real time
Stocks mentioned in the article
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
11,944 GBX | -0.68% | +9.37% | 233B | ||
2,938 JPY | +1.73% | +1.70% | 1.24B | ||
- Stock Market
- Stock Market News in real time
- Economy
- Astrazeneca Says Farxiga Reduced Death From Any Cause By 31% In Patients With Chronic Kidney Disease (Ckd) In Dapa-Ckd Trial